Accepted Manuscript A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids Susan Coote, PhD Lonan Hughes, MSc Gary Rainsford, MSc Conor Minogue, Alan Donnelly, PhD PII:

S0003-9993(14)01128-9

DOI:

10.1016/j.apmr.2014.09.021

Reference:

YAPMR 55987

To appear in:

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Received Date: 16 April 2014 Revised Date:

18 July 2014

Accepted Date: 4 September 2014

Please cite this article as: Coote S, Hughes L, Rainsford G, Minogue C, Donnelly A, A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids, ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2014), doi: 10.1016/j.apmr.2014.09.021. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT Title page Running Head; Augmenting resistance training with e-stim in MS Title: A pilot randomized trial of progressive resistance exercise augmented by

RI PT

neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids

SC

*Susan Coote, PhD, Clinical Therapies Department, University of Limerick, Limerick, Ireland

M AN U

Lonan Hughes, MSc, Clinical Therapies Department, University of Limerick, Limerick, Ireland

Gary Rainsford, MSc, BMR Neurotech, Galway, Ireland

TE D

Conor Minogue, BMR Neurotech, Galway, Ireland

Alan Donnelly, PhD, Physical Education and Sports Sciences Department, University of

AC C

EP

Limerick, Limerick, Ireland

*Corresponding author, [email protected], +353 61 234 278

Conflicts of Interest and Source of Funding: Disclosures: Conor Minogue and Gary Rainsford are employees of Biomedical Research Ltd, (BMR) BMR Neurotech, the manufacturers of the Kneehab device used in the study. Mr.

ACCEPTED MANUSCRIPT Minogue is co-inventor on patent US 7,957,816 which is assigned to BMR. They were not involved in data collection or analysis but contributed to the protocol development and final drafts of the paper. The study was funded by the Irish Research Council for Science Engineering and Technology and BMR Neurotech through the Enterprise Partnership

RI PT

Scheme. Dr. Coote reports grants from Multiple Sclerosis Ireland during the conduct of the study; grants from Irish Research Council, grants from Health Research Board Ireland, and fees from Biogen Idec, outside the submitted work. The other authors have nothing to

SC

disclose.

M AN U

Acknowledgements:

We would like to thank Dr Jean Saunders, Statistical Consulting Unit at UL for her advice on the analysis of the data for this paper.

The authors would like to thank the members and staff of Multiple Sclerosis Ireland for

EP

TE D

making this study possible.

AC C

Abstract : 185 words Paper: 3562 words

These data were presented at the World Congress of Physical Therapy, Amsterdam, The Netherlands, 2011 and the Rehabilitation in MS Meeting, Turku, Finland, 2011

ACCEPTED MANUSCRIPT A pilot randomized trial of progressive resistance exercise augmented by neuromuscular

2

electrical stimulation for people with Multiple Sclerosis who use walking aids.

3

Abstract:

4

Objective: To investigate the feasibility and preliminary outcomes of a home progressive resistance

5

training program augmented by neuromuscular electrical stimulation.

6

Design: Randomized, controlled, pilot trial

7

Setting: Participants home

8

Participants: People with Multiple Sclerosis (n=37) who use a walking aid

9

Interventions: Twelve week home PRT program or the same augmented by NMES

SC

RI PT

1

Main outcome measures: strength using hand held dynamometry, repeated sit to stand test, Berg

11

balance scale, Timed Up and Go test (TUG), MS walking scale 12, MS Impact Scale 29v2, modified

12

Fatigue Impact Scale and the NMES group completed a device usability questionnaire.

13

Results: Only change in MFIS score was significantly greater in the NMES than the PRT group

14

(p=0.012). The NMES group improved significantly in quadriceps endurance (median of change 8.5,

15

p=0.043), balance (3.5, p=0.001), physical impact of MS (-8.3, p=0.001) and impact of fatigue (-17,

16

p=0.001). Participants rated the device as highly usable.

17

Conclusion: This pilot study suggests that a home PRT program with NMES is feasible and the

18

Kneehab device is usable by this population. Only the reduction in impact of fatigue was greater in

19

the NMES than the PRT group.

EP

TE D

M AN U

10

AC C

20 21

Key words

22

Therapeutic electrical Stimulation, Multiple Sclerosis, mobility limitation, rehabilitation

23

Abbreviations

24

MS = multiple sclerosis

25

PRT = progressive resistance training

26

NMES = neuromuscular electrical stimulation

27

MFIS = modified fatigue impact scale

28

MSIS = multiple sclerosis impact scale 29v2

29

HHD = hand held dynamometry

30

TUG = timed up and go test

31

BBS = Berg balance scale

32

VAS = Visual analogue scale

33

MSWS – multiple sclerosis walking scale 12

34

SC

35

RI PT

ACCEPTED MANUSCRIPT

Muscle weakness in people with MS has been shown to increase with disability1 and studies have

37

demonstrated an association between strength reductions and decreases in walking speed2, 3.

38

Significant muscle weakness, often in combination with impaired balance, is one primary reason for

39

the prescription of walking aids for people with MS.

40

A review of exercise interventions for people with MS4 suggests that progressive resistance training

41

(PRT) is well tolerated and effective and recent studies have confirmed the benefits of PRT5-7 for

42

people with MS. Although several studies included people who use walking aids7-10, it is unclear how

43

people with more severe impairments and activity limitations responded to the interventions, as the

44

analysis did not separate their results.

45

Given the difficulties with mobility and transport for those with greater disability, home exercise

46

programs are frequently used in clinical practice. There are only a small number of studies to suggest

47

their effectiveness for people with MS on outcomes such as strength8, 11 and mobility11, 12.

48

Neuromuscular electrical stimulation (NMES) for neurological populations has been shown to

49

increase muscle activation13, enhance neuroplastic changes14 and may augment muscle contraction for

50

those with strength deficits15. A review of the evidence in neurological conditions concluded that a

51

modest benefit16 is evident, but that additional benefits to those of PRT are unclear.

AC C

EP

TE D

M AN U

36

ACCEPTED MANUSCRIPT In a recent study, Broekmans et al17 compared the effect of adding NMES to a 20 week PRT program,

53

to PRT alone. In their mildly disabled population of people with MS (only one person in the

54

stimulation group used a walking aid) both interventions showed similar positive effects on strength

55

that did not translate to change on functional measures. Similarly, Chang et al18 investigated the

56

effects of 8 weeks of surface electrical stimulation of the quadriceps muscle in people with MS. After

57

their home based program with 7 people with an Expanded Disability Status Scale (EDSS) up to 4,

58

they found significant improvements in general and central fatigue of the muscle that were associated

59

with improvements in perceived fatigue as measured by the modified fatigue impact scale (MFIS).

60

Ratchford et al11 specifically investigated the effect of NMES applied during cycling in people with

61

significant disability (EDSS 5-7). Following an 8 week home program with an FES cycle device they

62

found modest increases in strength and significant improvements in walking tests, and in perceived

63

physical health.

64

The above studies suggest that NMES may be a useful therapeutic tool for people with MS. However,

65

it is unclear whether it offers superior effects to PRT alone, and only one study11 has specifically

66

investigated people with MS who have greater disability and use a walking aid. It is also unclear

67

whether the improvements seen due to NMES and PRT programs translate to improvements in

68

function.

69

The Kneehab® is a NMES device that has been shown to augment strength and function compared to

70

voluntary contraction in people post anterior cruciate ligament construction19. In addition, an 8 week

71

home-based, pre-habilitation program in patients undergoing total knee arthroplasty found that

72

quadriceps strength increased by 28% and was associated with gains in functional outcomes20.

73

This aim of this study therefore was to investigate the feasibility and preliminary outcomes of a home

74

progressive resistance training program augmented by neuromuscular electrical stimulation. The

75

specific objectives were 1) to compare the outcome from a home program of PRT to the same

76

program augmented with the Kneehab at the level of body functions, activities and participation and

77

2) to investigate the usability of the Kneehab device for this population.

AC C

EP

TE D

M AN U

SC

RI PT

52

ACCEPTED MANUSCRIPT 78

Methods:

79 Approval for this study was granted by the University of Limerick, Education and Health Sciences

81

Ethics Committee. Written informed consent was obtained from participants prior to the baseline

82

assessment.

RI PT

80

83 Study Design

SC

84

M AN U

85

People with MS were recruited through the MS Society of Ireland from April to June 2010.

87

Participants were included if they used a walking aid most of the time and could walk at least 10

88

meters unaided. Participants were excluded if they had contra-indications to electrical stimulation, had

89

participated in an exercise program in the last month and had a relapse or commenced steroids in the

90

previous 3 months.

91

We conducted a randomised controlled pilot study with blinded outcome assessment. Participants

92

completed a home program of PRT or the same intervention with the Kneehab device. The

93

randomization sequence was generated by placing 3 PRT and 3 Kneehab cards into an envelope and

94

drawing and replacing until a sequence of 60 randomizations was generated. The sequence of

95

allocation was concealed from all study personnel until the end of the study.

96

Outcome assessment was completed in the participant’s home pre- and post-intervention (week 0 and

97

12) by an assessor who was blind to group allocation. Following baseline assessment the participants

98

were taught the PRT program, and provided with an exercise manual. Participants randomized to the

99

Kneehab group were taught how to use the device by a second non-blinded investigator.

100

AC C

EP

TE D

86

ACCEPTED MANUSCRIPT 101

Outcome Measures

102 103 Strength was measured using the JTech Power Track II® (JTech Medical) hand-held dynamometer

105

(HHD). Knee extension strength was the primary outcome and was measured in sitting21. Hip

106

extension strength was also measured in prone with the knee flexed, on a portable plinth. The average

107

of three “make” tests was used. The reliability and validity of HHD in neurological populations has

108

been established previously (Kolber & Cleland 2005).

109

Quadriceps muscle endurance was measured using a novel repeated sit-to-stand test. Participants were

110

instructed to stand up and sit down from a 45cm high chair without using their hands as many times

111

as they could. The test ended if participants sat for more than 3 seconds, used their hands or failed in

112

an attempted sit to stand.

113

A visual analogue scale (VAS) was used to evaluate lower limb spasticity. Participants were asked

114

how much their daily activities have been affected by tone in the past four weeks, and marked a

115

100mm line with the descriptors “Activities not affected at all”, and “Activities severely affected”.

116

Mobility was evaluated with the Timed Up and Go Test with the instructions “walk quickly but

117

safely”. The TUG has high reproducibility in an MS population22. Additionally we used the Multiple

118

Sclerosis Walking Scale (MSWS-12), a 12 item patient reported measure of walking ability rated on a

119

5 point ordinal scale. The MSWS-12 has good convergent validity, excellent responsiveness23 and

120

high test-retest reliability24.

121

The Berg Balance Scale (BBS) consists of 14 functional tasks rated from 0 to 4. The BBS has

122

acceptable concurrent validity25 and its intra- and inter-rater reliability were found to be superior to

123

three other balance scales26 in people with MS.

124

At a participation level, impact of MS was evaluated with the Multiple Sclerosis Impact Scale (MSIS-

125

29v2). It consists of 29 questions rated on a 4 point ordinal scale (1-4)27. Scoring of the MSIS29v2

AC C

EP

TE D

M AN U

SC

RI PT

104

ACCEPTED MANUSCRIPT physical and psychological subscales is transformed to a 0-100 scale, and the scale has robust

127

psychometric properties27.

128

The Modified Fatigue Impact Scale (MFIS) was used to assess the impact of fatigue. The MFIS is a

129

21 item questionnaire rated on a 4 point ordinal scale. It has demonstrated moderate to excellent

130

reproducibility in people with MS28.

131

In order to monitor adherence participants recorded the number of training sessions they completed in

132

a training diary. Participants in the Kneehab group also completed a 6 item questionnaire anchored by

133

a Likert scale from strongly disagree to strongly agree on their satisfaction and the usability of the

134

device.

SC

M AN U

135 136

RI PT

126

Intervention Protocol

137

The 12 week PRT program was completed twice a week for the first 6 weeks and 3 times a week from

139

week 7 to 12. This training frequency was selected based upon the recommendations for resistance

140

training by the American College for Sports Medicine29 and was previously adopted by a number of

141

the PRT studies for people with MS3, 7, 8, 10, 30. The program consisted of 6 lower limb exercises that

142

were completed in the order shown in Table 1. The exercises were performed in the home

143

environment at stable surfaces such as a high backed chair or counter edge to reduce fall risk. The

144

Kneehab was worn on the weaker leg for the four quadriceps exercises, with the strength testing used

145

to indicate the weakest leg. In order to optimize form and technique the participants demonstrated the

146

exercises independently to the investigator at the first session and were reminded about this during the

147

weekly phone calls.

148



AC C

EP

TE D

138

ACCEPTED MANUSCRIPT In line with positive findings from previous studies3, 5, 8, participants progressed from 1 set of 12

150

repetitions to 3 sets of 12 repetitions, with the aim of failing to complete the last repetition. Once 3

151

sets of 12 repetitions could be completed, free-weights in the hands, around the ankle or in a backpack

152

were added in increments of 0.5 or 1 kilogram as advised during weekly phone calls. Rest periods of 2

153

to 3 minutes between sets were advised.

154

The Kneehab® (Figure 1) is a synthetic garment that consists of 4 electrodes strategically placed to

155

activate the quadriceps muscle through a novel Multipath® system. It is placed on the thigh and

156

attached using Velcro fastenings. The pre-set program parameters used were a frequency of 50Hz,

157

on/off time of 5/10 seconds, ramp up/down of 1/0.5 seconds. Participants were encouraged to use the

158

highest tolerable intensity.

159



160

162

Statistical Analysis

TE D

161

M AN U

SC

RI PT

149

Data were analyzed using IBM SPSS Statistics 19. Data were tested for normality using the Shaprio-

164

Wilk test and relevant parametric or non-parametric tests applied. Differences between the groups at

165

baseline were tested with an Independent T-Test, Mann Whitney U Test or Chi square test. The effect

166

of the intervention was analyzed only for those who completed the intervention. For normally

167

distributed variables mixed between-within subjects ANOVA were used to analyze the effect between

168

groups over time. Post hoc paired-samples t-test was conducted to investigate change within groups.

169

For non-parametric data, change within groups was evaluated with a Wilcoxon-Signed Rank test. A

170

change score was calculated by subtracting the pre (week 0) score from the post (week 12) score.

171

Between group differences were evaluated with a Mann Whitney U Test.

172

AC C

EP

163

ACCEPTED MANUSCRIPT 173

Results:

174 The flow of participants is outlined in Figure 2. Two participants in the NMES group were excluded

176

as they experienced muscle spasm while using the electrical stimulation device. Baseline

177

demographics are presented in Table 2, and there were no significant differences between the groups

178

at baseline.

179

Data from training diaries revealed that the NMES group completed significantly more sessions of the

180

intervention than the PRT group (p

Pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with multiple sclerosis who use walking aids.

To investigate the feasibility and preliminary outcomes of a home progressive resistance training (PRT) program augmented by neuromuscular electrical ...
2MB Sizes 0 Downloads 9 Views